Drug like HSP27 cross linkers with chromenone structure ameliorates pulmonary fibrosis

Background: Pulmonary fibrosis (PF) is a progressive lung disease characterized by fibroblast accumulation and collagen deposition, resulting in lung scarring and impaired gas exchange. Current treatments for idiopathic pulmonary fibrosis (IPF) have limited efficacy and significant side effects. Hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Young Jo, Jeon, Seulgi, Jin, Hee, Won, Hee Yeon, Jeong, Mi Gyeong, Cho, Yeseul, Hwang, Eun Sook, Na, Younghwa, Cho, Jaeho, Lee, Yun-Sil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352808/
https://www.ncbi.nlm.nih.gov/pubmed/37469871
http://dx.doi.org/10.3389/fphar.2023.1203033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352808/
https://www.ncbi.nlm.nih.gov/pubmed/37469871
http://dx.doi.org/10.3389/fphar.2023.1203033

Ejemplares similares